Can systemic inflammation reduce T4→T3 conversion and cause low T3 signaling despite normal TSH and free T4?

The physiological impact of systemic inflammation on thyroid metabolism is a well-documented phenomenon known as Non-Thyroidal Illness Syndrome (NTIS) or Euthyroid Sick Syndrome. This condition demonstrates how the body’s metabolic priorities shift during illness, often resulting in diminished active thyroid hormone levels despite seemingly normal primary markers of thyroid function.

Clinical evidence and patterns

Inflammatory states—ranging from acute infections and sepsis to chronic conditions like heart failure and kidney disease—consistently produce a specific "low-T3 pattern."

• Hormonal profiles: Research indicates that in the early or mild stages of systemic inflammation, serum T3 levels drop significantly, while thyroid-stimulating hormone (TSH) and free thyroxine (T4) often remain within conventional reference ranges.
• Prognostic value: Lower T3 levels in these contexts are not merely markers of disease but are strong predictors of clinical outcomes. For example, in hospitalized patients, low T3 is associated with increased mortality and longer recovery times, even when TSH is normal.
• Signaling impact: This pattern results in a functional state of cellular hypothyroidism in peripheral tissues, reducing active thyroid signaling and metabolic rate as a likely adaptive response to conserve energy during systemic stress.

Mechanistic explanations

The reduction in active T3 during inflammation is driven by a complex disruption of the enzymatic pathways that govern thyroid hormone metabolism.

• Cytokine-mediated inhibition: Pro-inflammatory cytokines, specifically interleukin-6 (IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-alpha (TNF-α), are the primary drivers. These cytokines activate the NF-κB pathway, which suppresses the mRNA expression of deiodinase enzymes.
• Deiodinase dysregulation: Systemic inflammation downregulates Type 1 (D1) and Type 2 (D2) deiodinases—the enzymes responsible for converting the precursor T4 into the active hormone T3. Simultaneously, it often upregulates Type 3 deiodinase (D3), which shunts T4 toward the metabolic dead-end of reverse T3 (rT3) and further degrades existing T3.
• HPT axis suppression: While TSH may remain "normal," it is often inappropriately low for the level of circulating T3. This occurs because inflammatory cytokines also act on the hypothalamus and pituitary gland, preventing the typical compensatory rise in TSH that would normally occur when thyroid hormone levels fall.

Bottom line

Systemic inflammation directly impairs the conversion of T4 to T3 by inhibiting deiodinase enzymes via cytokine pathways. This frequently results in a low-T3 state with reduced metabolic signaling, even when standard TSH and T4 tests appear normal.